Inorganic hybrid nanoparticles in cancer theranostics: understanding their combinations for better clinical translation

Drug resistance, tumor heterogeneity, and poor selectivity make cancer treatment with current modalities a challenging and complicated task. Careful planning of diagnosis and therapy is required to build new strategies for treatment and management of cancer. The amalgamation of therapeutics and diagnostics in a single nano agent, known as theranostics is now possible due to the emergence of nanotechnology. Theranostics offers opportunities for personalized medicine by real-time monitoring of drug accumulation and dynamic modification of treatment depending on individual patient needs. Thus potential to reform disease management is held by theranostic nanoparticles. Amongst other nanosystems, inorganic nanoparticles have been widely used for developing theranostic drug delivery systems due to their favorable intrinsic properties. The last decade has seen a surge in development of such theranostic nanoparticles in which various inorganic materials in different combinations have been engineered to maximize the output with respect to specific applications. For example, Fe₃O₄@Au nanoparticles were developed for MRI, hyperthermia and magnetically controlled drug delivery. Several such combinations leading to innovative theranostic applications and their underlying mechanisms have been highlighted in this review. A review of patents and clinical trials of inorganic theranostic nanoparticles is also presented through which we understood that clinical translation still remains in the nascent stage. Thus, it is necessary to find and understand reasons for lack of clinical translations. Therefore, we have discussed the challenges associated with bench-to-bed translation of such inorganic nanoparticles which show immense potential in vitro but fail to deliver in long run.     

聚合物纳米粒子用于给药载体

聚合物纳米粒子用于给药载体具有广阔的前景，本文按聚合物纳米粒子的主要制备方法（单体聚合法，聚合物后分散法和两亲性聚合物自组装法等）综述了它近十年来在药物靶向输送上的应用研究进展。     

Fabrication,characterization and in vivo evaluation of dexpanthenol sustained-release nanofibers for wound healing

In this study, wound dressings consisting of dexpanthenol (Dex)-loaded electrospun nanofibers were fabricated using polyvinyl alcohol (PVA)/sodium alginate (SA), and chitosan as the core and the shell, respectively. Considering the remarkable properties of chitosan, it was used as a shell against drug release and to improve the thermal stability, and tensile strength of the scaffold. By comparing the thermogravimetric, and tensile strength results of nanofibers with and without shell, it was revealed that the presence of chitosan in the shell side could improve the thermal stability and increased the tensile strength by about three times. The isotherm models of dexpanthenol release from the PVA/SA/Dex-CS scaffold was best described by the Langmuir model. Besides, Fourier transform infrared, scanning electron microscopy, and X-ray diffraction techniques were performed to characterize nanofibers. Furthermore, an in vivo investigation of a wound dressing with dexpanthenol showed better healing compared to the wound dressings without dexpanthenol.     

聚合物基抗癌药物载体的研究进展

癌症是导致世界死亡率居高不下的主导原因之一,利用抗癌药物,采用化学疗法治疗癌症是目前较为有效的方法之一。为了提高抗癌药物在体内的溶解性,增大药物在癌细胞内的累积量,增强对癌细胞的杀伤性,减小对正常组织细胞造成的毒害作用,抗癌药物载体从简单的抗癌药物-聚合物复合物、聚合物胶束、纳米粒子等简单结构逐渐向具有靶向性、环境刺激响应性、表面电荷反转性等特性的新型结构发展。本文综述了国内外抗癌药物载体的发展历程以及最新进展,着重对新型载体的制备和研究进行了论述。     

Advanced drug delivery systems: Nanotechnology of health design A review

Nanotechnology has finally and firmly entered the realm of drug delivery. Performances of intelligent drug delivery systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. This review describes the advanced drug delivery systems based on micelles, polymeric nanoparticles, and dendrimers. Polymeric carbon nanotubes and many others demonstrate a broad variety of useful properties. This review emphasizes the main requirements for developing new nanotech-nology-based drug delivery systems.     

高分子材料调控肿瘤免疫微环境的研究进展

随着肿瘤免疫疗法在临床应用取得巨大突破,通过抗肿瘤免疫反应提高抗肿瘤疗效的治疗方式受到了广泛的关注.然而,肿瘤组织存在复杂的免疫抑制性微环境,严重限制了部分免疫疗法的效果.长期以来,高分子材料作为重要的药物递送载体受到广泛关注,但是其在调控肿瘤免疫微环境的功能及应用方面尚未引起足够的重视.在本文中,我们一方面介绍了肿瘤组织形成免疫抑制性微环境的成因,如肿瘤组织存在多种免疫抑制性细胞,如调节性T细胞(Tregs)、髓系来源抑制性细胞(MDSCs)和肿瘤相关巨噬细胞(TAMs)等,以及免疫细胞、肿瘤细胞等分泌的大量细胞因子、趋化因子、代谢产物等.另一方面,重点介绍了近年来高分子材料作为载体递送免疫调节分子或发挥自身免疫调节功能,调控或逆转免疫抑制性微环境的策略和典型代表,证明了高分子材料在调控肿瘤免疫微环境,改善肿瘤治疗效果方面的巨大潜力.     

Nanoparticle-based electrochemical detection in conventional and miniaturized systems and their bioanalytical applications: a review

With recent advances in nanotechnology making more easily available the novel chemical and physical properties of metal nanoparticles (NPs), these have become extremely suitable for creating new sensing assays. Many kinds of NPs, including metal, metal-oxide, semiconductor and even composite-metal NPs, have been used for constructing electrochemical sensors. This article reviews the progress of NP-based electrochemical detection in recent applications, especially in bioanalysis, and summarizes the main functions of NPs in conventional and miniaturized systems. All references cited here generally show one or more of the following characteristics: a low detection limit, good signal amplification and simultaneous-detection capabilities.     

Opportunities for innovation: Building on the success of lipid nanoparticle vaccines

Lipid nanoparticle (LNP) formulations of messenger RNA (mRNA) have demonstrated high efficacy as vaccines against SARS-CoV-2. The success of these nanoformulations underscores the potential of LNPs as a delivery system for next-generation biological therapies. In this article, we highlight the key considerations necessary for engineering LNPs as a vaccine delivery system and explore areas for further optimisation. There remain opportunities to improve the protection of mRNA, optimise cytosolic delivery, target specific cells, minimise adverse side-effects and control the release of RNA from the particle. The modular nature of LNP formulations and the flexibility of mRNA as a payload provide many pathways to implement these strategies. Innovation in LNP vaccines is likely to accelerate with increased enthusiasm following recent successes; however, any advances will have implications for a broad range of therapeutic applications beyond vaccination such as gene therapy.     

Protein nanocage architectures for the delivery of therapeutic proteins

Protein assemblies with cage-like structures are found widely in Nature with a large diversity of structural properties and functionalities. These architectures provide both inspiration for biomimetic design and templates for bioengineering. Inspired by the native utility of protein nanocage (PNC) architectures for cargo loading, transport, and protection, significant effort has been put into the development of PNC-based biomedical applications, including therapeutic delivery. This review summarizes the designs of PNC architectures for the delivery of therapeutic proteins (categorized by the type of therapeutics) and highlights the achieved or potential advantages of the PNCs as delivery systems for these proteins.     

Redox-responsive polymer prodrug/AgNPs hybrid nanoparticles for drug delivery

The redox-responsive hybrid nanoparticles of P(MACPTS-co-MAGP)@AgNPs is developed for drug delivery and fluorescence monitoring of the drug release by applying the NSET-based strategy.     

Effect of a nano-sized natural clinoptilolite modified by the hexadecyltrimethyl ammonium surfactant on cephalexin drug delivery

The use of porous materials as host systems for medical applications has been considered in recent years. The aim of this work is to construct an efficient adsorbent for the adsorption and delivering of cephalexin. For this pupose, pretreated natural nano-sized clinoptilolite (NZ) was modified by the cationic hexadecyltrimethyl ammonium surfactant (HDTMA), and the obtained modified zeolite nanoparticles (SMZ) were used to design systems for storage and release of cephalexin (CPX). The adsorbed and released extents of the drug onto/from the modified zeolite were determined by UV–Vis spectroscopy. The results showed that both decreasing the particle size of clinoptilolite and modifying its surface significantly increase the adsorbed drug extent. All the compounds were characterized by SEM, TEM, FT–IR, TG/DTG, and XRD. TG/DTG and also FT–IR results showed sufficient loading amounts of HDTMA and CPX onto the raw and modified zeolite, respectively. It was proven by means of TG that the composites are more stable thermally when the admicelles contain cephalexin in their interior. IR spectroscopy studies indicated that the zeolite structure remained unchanged after the modification with the surfactant and after the cephalexin drug has been loaded. Due to the presence of hydroxyl and amine groups in the cephalexin structure, pH plays an important role on the adsorbed CPX extent, so that the maximum adsorbed CPX was observed at pH = 12. While the delivery of CPX was better at pH = 2, because at alkaline pHs, the anionic carboxylate form of CPX has higher attractive force with the positive head of the surfactant on the SMZ. Hence, the stomach's acidic pH is appropriate for drug delivery. The effects of some cations in the delivery extent confirm that the diet can significantly affect the delivery of the CPX from the proposed adsorbent.     

Emerging methods for the fabrication of polymer capsules

Hollow polymer capsules are attracting increasing research interest due to their potential application as drug delivery vectors, sensors, biomimetic nano- or multi-compartment reactors and catalysts. Thus, significant effort has been directed toward tuning their size, composition, morphology, and functionality to further their application. In this review, we provide an overview of emerging techniques for the fabrication of polymer capsules, encompassing: self-assembly, layer-by-layer assembly, single-step polymer adsorption, bio-inspired assembly, surface polymerization, and ultrasound assembly. These techniques can be applied to prepare polymer capsules with diverse functionality and physicochemical properties, which may fulfill specific requirements in various areas. In addition, we critically evaluate the challenges associated with the application of polymer capsules in drug delivery systems.     

Poly(ethylene oxide)-poly(styrene oxide)-poly(ethylene oxide) copolymers: Micellization, drug solubilization, and gelling features

Two new poly(ethylene oxide)-poly(styrene oxide) triblock copolymers (PEO-PSO-PEO) with optimized block lengths selected on the basis of previous studies were synthesized with the aim of achieving a maximal solubilization ability and a suitable sustained release, while keeping very low material expense and excellent aqueous copolymer solubility. The self-assembling and gelling properties of these copolymers were characterized by means of light scattering, fluorescence spectroscopy, transmission electron microscopy, and rheometry. Both copolymers formed spherical micelles (12-14 nm) at very low concentrations. At larger concentration (>25 wt%), copolymer solutions showed a rich phase behavior, with the appearance of two types of rheologically active (more viscous) fluids and of physical gels depending on solution temperature and concentration. The copolymer behaved notably different despite their relatively similar block lengths. The ability of the polymeric micellar solutions to solubilize the antifungal drug griseofulvin was evaluated and compared to that reported for other structurally-related block copolymers. Drug solubilization values up to 55 mg g⁻¹ were achieved, which are greater than those obtained by previously analyzed poly(ethylene oxide)-poly(styrene oxide), poly(ethylene oxide)-poly(butylene oxide), and poly(ethylene oxide)-poly(propylene oxide) block copolymers. The results indicate that the selected SO/EO ratio and copolymer block lengths were optimal for simultaneously achieving low critical micelle concentrations (cmc) values and large drug encapsulation ability. The amount of drug released from the polymeric micelles was larger at pH 7.4 than at acidic conditions, although still sustained over 1 day.     

Dendrimer as a versatile platform for biomedical application: A review

Modern chemistry is vastly fascinated by dendrimer chemistry, an area that is rapidly expanding and brimming with potential applications. Dendrimers are highly branched polymers that have multiple peripheral groups, interior cavities and they have many structural properties therefore Dendrimers play a crucial role in the fields of nanotechnology, pharmaceuticals, and medicinal chemistry. The terminal functional groups of dendrimers may be chemically linked to other moieties in order to adjust surface properties for applications such as biomimetic nanodevices. A variety of biologically active agents can be incorporated into dendrimers to create biologically active conjugates, including novel drug carriers, by utilizing the homogeneity of their three-dimensional architecture. The purpose of this review is to provide a brief overview of bio-inspired dendrimer applications, highlighting their use as drug and gene delivery agents, and biomedical diagnostic agents. In addition, the review mentions briefly some dendrimer applications in cosmetics, agrochemicals, and catalyst.     

Melanin-based nanoparticles in biomedical applications: From molecular imaging to treatment of diseases

The melanin-based nanoparticles preparation methods were summarized here. Biomedical applications of melanin-based nanoparticles were also reviewed, including molecular imaging (magnetic resonance, positron emission tomography, and photoacoustic imaging) and treatment of diseases (drug delivery, photothermal therapy, antioxidant therapy, and iron overload therapy).     

聚合物复合物层层组装膜的高效负载及大分子和小分子药物的差别性释放

基于聚合物复合物和层层组装技术实现了大分子药物硫酸软骨素和小分子药物头孢曲松钠在聚合物膜中的高效负载以及差别性释放. 壳聚糖(CHI)和大分子药物硫酸软骨素(CSS)通过静电相互作用力复合, 制备了壳聚糖-硫酸软骨素复合物(CHI-CSS). 以CHI-CSS复合物和透明质酸(HA)为构筑基元, 通过层层组装构筑负载有硫酸软骨素的聚合物复合物膜. 利用后扩散的负载方法将小分子药物头孢曲松钠(CTX)负载到聚合物膜中, 从而实现大分子和小分子2种药物在聚合物膜中的负载. 聚合物膜中负载的CTX和CSS在生理条件下具有快慢不同的差别性释放动力学特性, CTX在6 h内快速释放, 而CSS长效缓释长达14 d. 快速释放的抗生素CTX能够有效抑制细菌感染, 而酶降解作用下缓慢释放的CSS可促进伤口愈合, 在包括头颈外科在内的外科术后感染防治领域有良好应用前景.     

Monoclonal Antibody-conjugated Polyphosphoester-hyd-DOX Prodrug Nanoparticles for Targeted Chemotherapy of Liver Cancer Cells

In order to overcome the limitation of traditional active nano-therapeutic drugs on tumor targeting efficiency which cannot reach the receptor/target in sufficient amount in the body, in this work, we developed a monoclonal antibody(mAb) and a polymer-hyd-doxorubicin prodrug conjugate, which enables the self-assembled nanoparticles to have precise targeting, tumor tissue aggregation and pH-sensitive drug release. We first prepared an amphiphilic polymer prodrug, abbreviated as H₂N-PEE...     

Controlled release of 4-hydroperoxycyclophosphamide from the fatty acid dimer-sebacic acid copolymer

Controlled polymeric release of chemotherapeutic agents has shown promise in the management of malignant gliomas. 4-Hydroperoxycyclophosphamide (4HC), loaded on the fatty acid dimer–sebacic acid copolymer (FAD:SA, 1:1), significantly prolonged survival in rats implanted with F98 and 9L gliomas. Here, we studied the in vitro and in vivo release kinetics in phosphate-buffered saline and rat brain of 20% 4HC/FAD:SA (wt:wt), the optimal dose for treatment of rat gliomas. In vitro release under infinite sink conditions was steady over the initial 12 hr to a peak of 20–35% of impregnated drug, consistent with early phase control via surface erosion. Release over the next 3 weeks was minimal, consistent with barrier formation around the polymer by an oily fatty acid dimer degradation product and consequent slowing of release. However, the polymer started to disintegrate by day 4, and there were minimal visible remnants by 3 weeks. Thus, a considerable amount of polymer-carried drug was probably lost in the disintegrating fragments. Also, drug loss is expected from its inherent hydrolytic instability. In vivo release into brain revealed two peak levels of drug at 0–1 hr and 5–20 days. With loaded polymer implanted intraperitoneally or cyclophosphamide injected systemically, peak brain drug levels were measured in 2–8 hr, with substantial decrease by 48 hr without a second peak. Brain levels were substantially higher than blood levels at all time periods. We conclude that FAD:SA (1:1) adequately protects the otherwise labile 4HC, allowing effective and substained drug release in vivo. Furthermore, it should be possible to modify the polymer to adjust the time of peak release for more beneficial therapeutic effects.     

An overview of polymeric nanomicelles in clinical trials and on the market

Polymeric nanomedicine is a promising and rapidly evolving field.Among the different polymeric carriers,polymeric micelle(PM) with nanoscale size exhibit potent physical and biological advantages including excellent solubility and pharmacokinetics,enhanced efficacy and lower toxicity.PM has garnered increasing intere st in research and in the clinic.This review will highlight the clinical outcomes of several PM-based formulations,and further summarized their preparation methods,strengths and challenges.